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ABSTRACT Several biologically important peripheral (e.g., myristoylated alanine-rich C kinase substrate) and integral (e.g.,
the epidermal growth factor receptor) membrane proteins contain clusters of basic residues that interact with acidic lipids in the
plasma membrane. Previous measurements demonstrate that the polyvalent acidic lipid phosphatidylinositol 4,5-bisphosphate
is bound electrostatically (i.e., sequestered) by membrane-adsorbed basic peptides corresponding to these clusters. We report
here three experimental observations that suggest monovalent acidic lipids are not sequestered by membrane-bound basic
peptides. 1), Binding of basic peptides to vesicles does not decrease when the temperature is lowered below the ﬂuid-to-gel
phase transition. 2), The binding energy of Lys-13 to lipid vesicles increases linearly with the fraction of monovalent acidic lipids.
3), Binding of basic peptides to vesicles produces no self-quenching of ﬂuorescent monovalent acidic lipids. One potential
explanation for these results is that membrane-bound basic peptides diffuse too rapidly for the monovalent lipids to be
sequestered. Indeed, our ﬂuorescence correlation spectroscopy measurements show basic peptides bound to phosphatidyl-
choline/phosphatidylserine membranes have a diffusion coefﬁcient approximately twofold higher than that of lipids, and those
bound to phosphatidylcholine/phosphatidylinositol 4,5-bisphosphate membranes have a diffusion coefﬁcient comparable to that
of lipids.
INTRODUCTION
The inner leaﬂet of the plasma membrane from a typical
mammalian cell contains both monovalent and polyvalent
acidic lipids. Numerous membrane proteins contain clusters
of basic residues that can interact with these negatively
charged lipids. Examples include peripheral proteins such as
Src, K-Ras4B, myristoylated alanine-rich C kinase substrate
(MARCKS), growth-associated protein43/neuromodulin
(GAP43), and A kinase anchoring protein 12 (also called
gravin), as well as integral proteins such as the epidermal
growth factor receptor (EGFR/ErbB) family of receptor ty-
rosine kinases and the ion channel N-methyl-D-aspartate re-
ceptor. Earlier work showed that the basic clusters on Src
(1,2), K-Ras4B (3–5), and MARCKS (6) help anchor and
target these proteins to the plasma membrane; the cytoplas-
mic leaﬂet of this membrane has a more negative electro-
static surface potential than the cytoplasmic leaﬂets of
internal membranes (7). Integral membrane proteins or dou-
bly palmitoylated proteins (e.g., GAP43), however, do not
require basic/hydrophobic regions formembrane binding, sug-
gesting that they may serve additional functions.
Experiments using three independent techniques (ﬂuores-
cence resonance energy transfer (FRET), electron paramag-
netic resonance, and the phospholipase-C-hydrolysis assay)
have shown that peptides corresponding to the basic domains
of MARCKS, EGFR, GAP43, and N-methyl-D-aspartate
reeptor laterally sequester polyvalent acidic lipids, such as
phosphatidylinositol-4,5-bisphosphate (PIP2), via nonspe-
ciﬁc electrostatics (8–10). This occurs because when basic
peptides bind to the membrane, they produce a local posi-
tive electrostatic potential that attracts polyvalent acidic
lipids (11,12). A detailed study of peptides with 13 basic
residues—Lys-13, Arg-13, and MARCKS(151–175), a
basic/hydrophobic peptide corresponding to the effector
domain of MARCKS (see Table 1 for sequence)—showed
that three PIP2 form an electrostatic complex with a single
peptide (8), even in the presence of physiological concen-
trations (15–30%) of monovalent acidic lipids (9). A peptide
corresponding to the MARCKS basic region is unstructured
in solution and when bound to a membrane (13–17), and the
other highly basic clusters may also be extended rather than
helical. The targeting of structured domains to membranes
is reviewed elsewhere (18).
This sequestration of PIP2 is reversible for
MARCKS(151–175); either binding of calcium/calmodulin
or PKC phosphorylation of three Ser can reverse membrane
binding of both the peptide and native protein, and thus PIP2
sequestration (19–22). Calcium/calmodulin or PKC phos-
phorylation of a Ser in the basic cluster of K-Ras4B can also
reverse the binding of this protein to the plasma membrane
(23–25). Proteins containing clusters enriched in basic and
hydrophobic residues may control the local free concentra-
tion of PIP2 in the plasma membrane by sequestering the
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lipids electrostatically and releasing them in response to
calcium/calmodulin (12).
Theoretical analyses also predict that the local positive
potential produced by a membrane-adsorbed basic peptide
will attract monovalent acidic lipids, suggesting that they,
too, should accumulate adjacent to the peptide, but less
strongly than polyvalent lipids (26–29). We used several
techniques to test the degree to which membrane-bound
basic and basic/hydrophobic peptides laterally sequester mono-
valent acidic lipids, ﬁrst measuring the effects of simple
basic peptides, then analyzing more complex basic/hydro-
phobic peptides.
Data from numerous binding experiments indicate that
nonspeciﬁc electrostatic interactions govern the association
of simple basic peptides with lipid bilayer membranes. The
peptides bind outside the envelope of the lipid polar head-
groups (30–32), suggesting that hydrophobic interactions are
negligible. Increasing the number of basic residues increases
the binding energy linearly, as does increasing the mol frac-
tion of acidic lipid in the membrane (32), whereas increasing
the salt concentration in the solution reduces binding (32).
Finally, neither the chemical nature of the acidic lipids nor that
of the basic amino acids affects the binding strongly (31).
Binding studies with basic/hydrophobic peptides suggest that
they, too, interact with membranes mainly through electro-
static interactions, provided the membrane contains a signif-
icant fraction of acidic lipids (10,15,33); the hydrophobic
residues penetrate the bilayer, but generally make a smaller
contribution to the binding energy (9,14,16,17).
We used three different approaches to test whether basic
peptides laterally sequester monovalent acidic lipids. 1), We
compared the binding of basic peptides to vesicles at
temperatures below and above the gel-to-liquid-crystalline
phase transition; this should vary only if the peptides perturb
the initially random lipid distribution in the ﬂuid membranes.
2), We measured the binding energy of a simple basic
peptide to lipid vesicles with increasing fractions of mon-
ovalent acidic lipids; the energy should increase linearly if
the peptide does not sequester the acidic lipids (34). 3), We
tested whether basic or basic/hydrophobic peptides produce
self-quenching of NBD-labeled phosphatidylserine (PS) in
vesicles; self-quenching should occur only if the peptides
sequester the lipid. Finally, we measured the diffusion
constants of ﬂuorescently labeled lipids and membrane-
bound peptides using ﬂuorescence correlation spectroscopy
(FCS); the results suggest that the relatively rapid diffusion
of the peptide may explain the lack of monovalent lipid se-
questration.
MATERIALS AND METHODS
Materials
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC),1-palmito-
yl-2-oleoyl-sn-glycero-3-phosphatidylserine (POPS), 1,2-dimyristoyl-sn-
glycero-3-phosphatidylcholine (DMPC), 1,2-dimyristoyl-sn-glycero-3-
[phospho-rac-(1-glycerol)] (DMPG), 1-palmitoyl-2-[6-[(7-nitro-2-1,3-ben-
zoxadiazol-4-yl)amino]caproyl]-sn-glycero-3-phosphatidylcholine (NBD-
PC) and 1-oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodeca-
noyl]-sn-glycero-3-phosphatidylserine (NDB-PS), and triammonium salt of
PIP2 from porcine brain were purchased from Avanti Polar Lipids (Alabaster,
AL). 1,19-dioctadecyl-3,3,39,39-tetramethylindodicarbocyanine,4-chloroben-
zenesulfonate (DiD), N-(4,4-diﬂuoro-5,7-dimethyl-4-bora-3a,4a,-diaza-
s-indacene-3-propionyl)-1-hexadecanoyl-sn-glycero-3-phosphatidylcholine
(BODIPY-FL-PC), and Alexa488 were purchased from Molecular Probes
(Eugene, OR). Rhodamine 6G was purchased from Sigma (St. Louis, MO).
Radioactively labeled [dioleoyl-1-14C]-L-a-dioleoyl-phosphatidylcholine
and [ethyl-1,2-3H] N-ethylmaleimide (3H-NEM) were from PerkinElmer
Life Sciences (Boston, MA). BODIPY-TMR-C16-PIP2 and NBD-PIP2 were
purchased from Echelon (Salt Lake City, UT). Table 1 shows the sequences
of the basic or basic/hydrophobic peptides, purchased from American
Peptide Co. (Sunnyvale, CA). Peptides used for experiments were
determined to be .95% pure by high-performance liquid chromatography
and matrix-assisted laser desorption ionization time-of-ﬂight mass spectros-
copy.
Peptide labeling
We labeled peptides with radioactive 3H-NEM as described previously
(9,15). Brieﬂy, we placed 250 mCi of 3H-NEM in pentane on top of 20 ml of
N,N9-dimethylformamide (DMF), evaporated the pentane with argon gas,
then mixed the 3H-NEM in DMF with 1 ml of 1 mM peptide solution. We
blocked the unlabeled cysteines on the peptide by adding an excess of
nonradioactive NEM (mol ratio of 1.5:1 NEM/peptide). We modiﬁed a
protocol from ‘‘Conjugation with Thiol-Reactive Probes’’ (Molecular
Probes) to label peptides with the thiol-reactive Alexa488. Brieﬂy, we
mixed 1 ml of 1 mM peptide in 10 mM K2HPO4/KH2PO4, pH 7.0, with the
probe dissolved in DMF (1:1 probe/peptide molar ratio) and incubated it for
at least 1 h. Labeled peptides were puriﬁed .95% using high-performance
liquid chromatography (Proteomics Center, State University of New York,
Stony Brook, NY).
Vesicle preparations
We used large unilamellar vesicles (LUVs;, diameter 100 nm) for the
centrifugation binding and self-quenching experiments, as described in
detail elsewhere (9,15,35). Brieﬂy, we added solutions containing the
appropriate lipid mixture in chloroform to a 50-ml round-bottom ﬂask,
attached the ﬂask to a rotary evaporator, and rotated without vacuum for;5
min with the ﬂask well immersed in a 30–35C water bath. We then applied
the maximum vacuum that does not boil the chloroform until most of the
solvent evaporated, followed by evaporation under full vacuum for at least
30 min to remove traces of chloroform. We added the appropriate solution
TABLE 1 Sequences of peptides
Peptide Sequence
MARCKS(151–175) CKKKKKRFSFKKSFKLSGFSFKKNKK
FA-MARCKS(151–175) CKKKKKRASAKKSAKLSGASAKKNKK
ErbB1(645–660) CRRRHIVRKRTLRRLLQ
Lys-13 CKKKKKKKKKKKKK
Arg-13 CRRRRRRRRRRRRR
Basic residues are shown in bold and aromatic residues are underlined. The
N-terminus of each peptide is blocked with an acetyl group and the
C-terminus is blocked with an amide group. Cysteine residues were added
at the N-terminus to facilitate attachment of ﬂuorescent or radioactive
labels. MARCKS(151–175) corresponds to the bovine effector domain. The
effector domain of human MARCKS has an identical sequence.
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(100 mMKCl, 1 mMMOPS, pH 7.0, for vesicles used in self-quenching and
FCS experiments, 176 mM sucrose, 1 mMMOPS, pH 7.0, for vesicles used
in centrifugation binding experiments, which require sucrose-loaded LUVs)
to form multilamellar vesicles, which were then subjected to a rapid freeze-
and-thaw cycle ﬁve times. LUVs were formed by extruding multilamellar
vesicles through 100-nm-diameter polycarbonate ﬁlters 10 times. For ves-
icles used in centrifugation measurements, the outer solution of the sucrose-
loaded LUVs was exchanged for 100 mM KCl, 1 mM MOPS, pH 7, via
ultracentrifugation. DMPC/DMPG vesicles for centrifugation binding
experiments were extruded and maintained at ;30C, signiﬁcantly above
the ﬂuid-to-gel phase transition of ;24C, until the centrifugation ex-
periment was performed.
We used both gentle hydration and rapid evaporation methods to form
giant unilamellar vesicles (GUVs) for FCS measurements (36,37). The
gentle hydration method involves drying the appropriate lipid mixture in
chloroform (9:1 phosphatidylcholine/phosphatidylserine (PC/PS) for lipid
diffusion measurements, which provides the negative charge necessary for
GUV formation in high-salt solutions; 0.01 mol % DiD for confocal imaging
of the GUVs, and 0.0001 mol % ﬂuorescent lipids for FCS measurements)
under vacuum for 30 min to form a thin ﬁlm, then prehydrating the dried ﬁlm
with argon-saturated water vapor at 35–40C for 1 h. We then added 1–2 ml
of buffer solution (100 mM KCl, 1 mMMOPS, pH 7.0, warmed to the same
temperature as hydrated lipids) containing 10–100 nM Alexa488-labeled
peptides and incubated the sealed ﬂask for 5–12 h at room temperature. As
the GUVs form they trap the peptide inside and, because basic peptides bind
to glass with high afﬁnity, essentially all peptides bound to the GUVs are on
the inner leaﬂet of the vesicles We harvested 100–200 ml of the upper part of
the solution and transferred the GUVs to a chamber composed of glass
coverslip and a microscope glass slide sandwiched with thermoplastic
material. Only 10–20% of the GUVs were useful for FCS measurements
(5–30 mm diameter, unaggregated, single-walled GUVs). We also used the
gentle hydration method to prepare GUVs directly on a microscope
coverglass held in a stainless steel chamber with Teﬂon insert designed by
R. Galneder in the Ludwig-Maximilians-Universita¨t, Sektion fu¨r Physik,
Mu¨nich, Germany; the lipid mixture was exposed only to Teﬂon and glass.
We deposited small drops of the appropriate lipid mixture in chloroform
(;0.01 mg/ml) on the coverglass to form thin ﬁlm. Further steps were
similar to previous methods. Due to the problems with incorporation of PIP2,
GUVs containing this lipid were prepared in round-bottom ﬂasks using the
gentle hydration method. To measure diffusion of Alexa488-labeled pep-
tides bound to the outer leaﬂet of the GUVs, we used GUVs prepared
directly on the glass coverslip and added 10 nM Alexa488-labeled peptide
5 min before the FCS data recording. The rapid evaporation method (37)
involves carefully adding 2 ml of Alexa488-labeled peptide solution (100
mM KCl, 1 mM MOPS, pH 7.0) to a 50-ml round-bottom ﬂask containing
20 ml of 0.1 M lipid mixture dissolved in 320 ml of chloroform and 70 ml of
methanol. Two minutes under vacuum on a rotary evaporator produces an
opalescent ﬂuid containing ;10% single-walled GUVs, as reported pre-
viously (38). This method had the advantage of producing GUVs rapidly.
Diffusion measurements with vesicles produced by both methods yielded
identical results.
Centrifugation binding experiments
We measured binding of 3H-NEM-labeled peptides to sucrose-loaded
DMPC/DMPG, POPC/POPG, and POPC/POPS LUVs using the centrifu-
gation technique described in detail elsewhere (9,15,35). Brieﬂy, we mixed
trace concentrations of labeled peptide (2–10 nM) with sucrose-loaded
LUVs and centrifuged at 100,000 g for 1 h. (We added 100 mM of PC in the
form of sonicated vesicles to the experimental mixture to minimize loss of
the peptide onto the walls of the centrifuge tubes.) For the temperature
dependence experiments (Fig. 1), both mixing and centrifugation were done
at the given temperature (10, 17, or 30C). We used a substituted peptide,
F-A MARCKS(151–175), rather than MARCKS(151–175) for these
experiments because the aromatic Phe residues in the latter penetrate the
polar headgroup region of a liquid crystalline lipid bilayer (17), but pre-
sumably would be expelled from a gel-phase bilayer; this would complicate
interpretation of the results. The binding measurements reported in Fig. 2
were carried out at room temperature, 24C. We calculated the percent pep-
tide bound to the vesicles by comparing the radioactivity (liquid scintilla-
tion) or ﬂuorescence (spectroﬂuorometry) present in the supernatant and
pellet.
The fraction of peptide, P, bound through electrostatic/hydrophobic
interactions to membranes is given by Eq. 1:
½Pmem
½Ptotal
¼ K½Lacc
11K½Lacc
; (1)
where [P]mem is the concentration of membrane-bound peptide, [P]total is the
total concentration of the peptide, [L]acc is the accessible lipid concentration
(½ the total lipid concentration as the peptide is added to preformed
vesicles), and K is the molar partition coefﬁcient (the reciprocal of the
concentration of accessible lipid that binds 50% of the peptide); see Wang
et al. (15) and Peitzsch and McLaughlin (39) for details. We plot the fraction
of peptide bound to the membranes versus accessible lipid concentration
(e.g., Fig. 1 A) and determine the molar partition coefﬁcient from the least-
squares ﬁt of Eq. 1 to the data points.
Fluorescence quenching experiments
We measured self-quenching using an SLM-AMINCO spectroﬂuorometer
(Foster City, CA). Experiments using NDB labels used a 470-nm excitation
wavelength and emission spectra were collected from 500 to 600 nm;
experiments using BODIPY-TMR labels used a 547-nm excitation wave-
length and emission spectra were collected from 560 to 660 nm. The emis-
sion spectra were collected as we added unlabeled peptide to the solution
containing the LUVs. We used Eq. 2 to calculate the percentage of
quenching:
% quenching ¼ 1 Ip
I
; (2)
where Ip is the intensity of ﬂuorescence emitted from labeled lipid in the
presence of peptide, and I is the intensity of ﬂuorescence emitted from
labeled lipid in the absence of peptide. The total lipid concentration was 0.1
mM and 0.75 mM for 5:1 PC/PS and 99:1 PC/PIP2 LUVs, respectively.
These concentrations are sufﬁciently high (as determined using the cen-
trifugation binding assay) to bind 99% of the MARCKS(151–175) or Lys-13
peptides in the solution.
The quenching experiments were performed with vesicles containing
ﬂuorescent lipids present at the maximal mol fractions that did not exhibit
appreciable self-quenching (4% for NBD-lipids and 1% for BODIPY-TMR-
PIP2 in the LUVs).
We determined the amount of self-quenching due to the proximity of
neighboring NBD lipids by measuring the NBD ﬂuorescence in LUVs
containing increasing percentages of NBD lipid (from 0 to 6% NBD-PC or
NBD-PS). We measured the ﬂuorescence of NBD lipid both in LUVs
(50 mM total lipid in 100 mM KCl, 1 mM MOPS, pH 7) and in a non-
membrane form in methanol, and calculated self-quenching (Fig. 3 A) using
Eq. 2, substituting the ﬂuorescence intensity of the NBD lipid in LUVs for Ip
and the corresponding intensity of NBD-lipid in methanol for I.
FCS diffusion measurements
Confocal imaging and FCS measurements were performed on a commercial
Zeiss (Jena, Germany) LSM 510 Meta/confocor 2 apparatus using standard
conﬁgurations. Minimal laser powers were chosen to avoid photobleaching
of the ﬂuorescent probes. We used a 403 NA 1.2 C-Apochromat water-
immersion objective and adjusted pinholes at least daily. The detection
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volume was calibrated by measuring the diffusion of rhodamine 6G (D¼ 2.8
3 106 cm2/s (40)) in the buffer solution (100 mM KCl, 1 mM MOPS, pH
7.0). The 1/e2 radius of the detection volume for the 488-nm line was
determined to be v1 ¼ 0.14 6 0.01 mm. We excited Alexa488, BODIPY-
FL, and BODIPY-TMR with the 488-nm line of the Argon laser and
collected emission spectra through a 505-530 BP ﬁlter (Alexa488, BODIPY-
FL) or a 505-600 BP ﬁlter (BODIPY-TMR). We monitored the count rate
during data acquisition and rejected measurements with a visible decrease to
avoid artifacts due to vesicle movements and bleaching. We used Sigma Plot
and a least-squares algorithm to ﬁt the autocorrelation curves to the model
equation for free Brownian diffusion in two dimensions commonly used in
FCS (41):
GðtÞ ¼ 1
N
3
1
11
t
td
; (3)
where td, is the average residence time and N is the average number of
particles in the measurement volume. We calculated the diffusion coefﬁ-
cient, D, from the Einstein relation (Eq. 4)
D ¼ v
2
1
4td
: (4)
For cases with i different populations of molecules (e.g., Alexa488-Lys-
13 on 4:1 and 5:1 PC/PS GUVs had a small but signiﬁcant fraction of
unbound peptide) moving with different diffusion coefﬁcients, Di, with
fractions equal to Yi, and residence times td,i ¼ v12/4Di, the expression
becomes (assuming they have the same ﬂuorescence quantum yields)
GiðtÞ ¼ 1
N
+
i
Yi
11
t
td;i
: (5)
GUVs were prepared with Alexa488-labeled basic peptides bound to
either the inner or outer leaﬂet of the membrane as described above. Using
the laser scanning microscope (LSM) module, we scanned the chamber and
selected GUVs with a diameter of 5–30 mm attached to the coverslip. GUVs
used for measurements had an average diameter;10 mm (see Fig. 4 A). The
effective concentration of lipids in the inner leaﬂet of a 10-mm-diameter
GUV is ;103 M, assuming they are distributed uniformly in the enclosed
volume). Alexa488-Lys-13 binds 3:1 PC/PS LUVs with K ¼ 1 3 105 M1;
thus, 99% of the peptides trapped inside such GUVs are bound to the
membrane. MARCKS(151–175) has higher afﬁnity for PC/PS membranes
and binds 5:1 PC/PS LUVs with a molar partition coefﬁcient K ;105 M1;
thus 99% of the enclosed peptides are bound to the membrane of a 10-mm-
diameter 5:1 PC/PS GUV. We ensured that we were measuring the D of
membrane-bound peptides by examining the relationship between D and the
mol fraction of PS in the vesicles: increasing the fraction of PS both
increases the peptide’s afﬁnity to and decreases its rate of dissociation from
membranes. We performed an axial (z) scan through the membrane before
the FCS recording and placed the laser focus on the top central membrane
region of the GUV (the point of the maximum ﬂuorescence intensity; see
cartoon in Fig. 4 B). We determined the amount of ﬂuorescence emitted by
Alexa488 ﬂuorophore in the solution for the given laser power. During data
acquisition we ensured that Alexa488-labeled peptides emit the same
amount of light.
We selected vesicles for measurement ﬁrst by discarding aggregated,
visibly multiple-shelled, or very bright GUVs (in LSMmode), then selecting
GUVs with sharper peaks and lower ﬂuorescence-intensity scans (in FCS
mode). We also examined several GUVs selected as putative unilamellar
vesicles using phasemicroscopy to conﬁrm that theywere indeed unilamellar.
We performed FCS measurements inside, above, and next to the GUVs to
determine the background signal from unbound peptide and from a free label
in the solution; we rejected samples with background .10%.
Because peptides trapped between multiple lamellae of a vesicle could
exhibit anomalously slow diffusion, we measured diffusion of Alexa488-
MARCKS(151–175) trapped in a visibly multiple-shelled vesicle: the signal
from such peptides was high, the number of particles was large, and the
diffusion was slow compared to measurements done on putative unilamellar
GUVs. As an additional control, we measured diffusion of peptides bound to
the outer leaﬂet of the GUVs prepared directly on the glass coverslips and
exposed to a 10-nM Alexa488-labeled peptide solution 5 min before the
measurements. We detected neither a signiﬁcant concentration of free
peptide in solution nor a signiﬁcant change in the number of peptides bound
to GUV during the measurement period. The measured value of D was
identical for peptides bound to the outer or inner leaﬂet of the GUV. These
results support our assumption that most of our measurements were made on
authentic unilamellar vesicles.
FCS binding measurements
FCS binding experiments were performed as described in detail elsewhere
(33). Brieﬂy, we precoated eight-well LabTechII chambers (Nunc,
Wiesbaden, Germany) with PC membranes (33) to prevent loss of the
peptide. The laser focus was placed in the solution 200 mm above the top of
the glass coverslip. LUVs are signiﬁcantly larger than the Alexa488-labeled
peptides, so single color autocorrelation measurements can distinguish be-
tween the correlation times for the free and bound peptide. We determined
the correlation time of free peptide (;60 ms) and 100-nm-diameter LUVs
(;1600 ms) separately. We used the ConfoCor2 software to ﬁt the auto-
correlation function to the collected data. In the three dimensions, Eq. 6
describes the autocorrelation function:
GðtÞ ¼ 1
N
 1
11
t
td
 1
11 ðSPÞ23 t
td
0
B@
1
CA
1
2
 11 Fe
 ttt
1 F
 
; (6)
where N is the number of ﬂuorescent particles in the confocal volume
(typically 1), SP (structure parameter) is the ratio between the equatorial and
axial radii of the confocal volume (;6), td is the average residence time of
the particle in the confocal volume, tt is the triplet state lifetime, and F is the
fraction of ﬂuorescent particles in the triplet state. In the case of a multi-
component system, the measured correlation function G( t) is a sum of the
autocorrelation functions of each component.
Statistical analysis
We used SigmaStat and SigmaPlot (SPSS, Chicago, IL) for statistical
analysis and curve ﬁtting, respectively. We compared the values of diffusion
coefﬁcient of membrane-bound peptides and lipids using Kruskal-Wallis
one-way analysis of variance on ranks, Dunn’s method, and one-way
analysis of variance, Tukey’s method (42). We concluded that the values are
signiﬁcantly different when P , 0.05.
RESULTS
Basic peptides bind equally strongly
to gel (frozen) and liquid-crystalline (ﬂuid)
lipid membranes
We measured the binding of two basic peptides, Arg-13
and F-A-MARCKS(151–175), see Table 1, to 5:1 DMPC/
DMPG vesicles at 10, 17, and 30C using a centrifugation
technique. DMPC and DMPG have similar liquid-to-gel
transition temperatures (Tc ; 24C) and these lipids
distribute randomly in the membrane below and above the
transition (43,44). Fig. 1 A shows the results of a typical
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experiment using Arg-13 at 10C. We calculated the molar
partition coefﬁcient, K, from a least-squares ﬁt of Eq. 1 to the
data. Fig. 1 B shows the values of K for binding of Arg-13
and F-A-MARCKS(151–175) to 5:1 DMPC/DMPG at the
three different temperatures: K does not change signiﬁcantly
with temperature (i.e., the peptides bind with similar afﬁnity
to frozen and ﬂuid membranes). We also measured Arg-13
binding to 10:1 DMPC/DMPG vesicles because reducing the
mol fraction of acidic lipid should make any phase-related
differences in binding more pronounced. Again, we ob-
served no signiﬁcant differences in binding: K ¼ 1 3 104
M1 at 10, 17, and 30C (data not shown). As a control, we
measured the binding of Arg-13 and F-A-MARCKS(151–
175) to 5:1 POPC/POPG vesicles, which remain in a liquid
crystalline state at 10, 17, and 30C, and found no sig-
niﬁcant differences in K (data not shown).
The simplest explanation for the observation that changing
the membrane from a gel to a liquid-crystalline state does not
affect peptide binding is that the peptides do not cause lateral
redistribution of monovalent acidic lipids when they bind.
The rationale here is simple: the diffusion constant of the
lipids decreases ;1000-fold in the gel state (45); the
diffusion constant of the peptide does not decrease markedly
(not shown). Thus, a rapidly diffusing peptide will skate over
the frozen surface of the membrane and not perturb the ran-
dom distribution of the lipids. As the binding energy is the
same when the membrane is in a liquid/crystalline state (Fig.
1 B), the simplest interpretation is that the peptide also does
not perturb the random distribution of the lipids when it
binds to the ﬂuid membrane.
The molar partition coefﬁcient, K, of basic
peptides increases exponentially with increasing
mol fraction of acidic lipids in the membrane
Wemeasured the binding of the basic peptide Lys-13 (Table 1)
to LUVs composed of mixtures of the zwitteronic phospho-
lipid POPC and the monovalent acidic lipid POPS using a
centrifugation technique. Fig. 2 A shows the results of two
typical experiments with LUVs: K ¼ 1 3 104 M1 or K ¼
FIGURE 1 Binding of Arg-13 and F-A-
MARCKS(151–175) to DMPC/DMPG
LUVS does not depend on the state of the
lipids. (A) Binding of radioactively labeled
Arg-13 to 5:1 DMPC/DMPG LUVs at
10C. The percent of peptide bound was
determined as a function of accessible lipid
concentration, [lipid], using a centrifuga-
tion technique. The curve represents the
least-squares ﬁt of Eq. 1 to the data. The
molar partition coefﬁcient, K (reciprocal of
accessible lipid concentration that binds
50% of the peptide), is 1.4 3 105 M1.
Experiments were conducted at 10C,
17C, and 30C, and the average values
of K are plotted in B. (B) Temperature
dependence of the molar partition coefﬁ-
cient, K, for Arg-13 (d) and F-A-MARCKS(151–175) (=) binding to 5:1 DMPC/DMPG LUVs. Each point represents an average (6 SD) of at least three
independent experiments similar to those shown in A. For all results in Figs. 1–4, the external solutions contained 100 mM KCl, 1 mM MOPS, pH 7.0.
FIGURE 2 Binding of Lys-13 to PC/PS
LUVS increases exponentially with the mol
fraction of PS in the vesicles. (A) Binding of
3H-NEM-labeled Lys-13 to PC/PS LUVs
containing either 15% (n) or 20% (h) PS.
The percent of peptide bound was deter-
mined as a function of accessible lipid
concentration using a centrifugation tech-
nique. The curves represent the least-
squares ﬁt of Eq. 1 to the data. K ¼
13 104 M1 and 13 105 M1 for vesicles
with 15% and 20% PS, respectively. The
average value of K (6 SD, n ¼ 6) is plotted
in B, together with the results of similar
experiments with PC/PS vesicles contain-
ing different mol fractions of PS. (B) The
molar partition coefﬁcient, K, of 3H-NEM-
labeled Lys-13 as a function of the mol % PS in the PC/PS LUVs (s). Note that K increases exponentially with mol % PS. (Control experiments with
Alexa488-Lys-13 produced identical values of K from centrifugation (d), and from FCS measurements (:).)
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13 105 M1 for vesicles containing POPC and 15% or 20%
PS, respectively. Fig. 2 B is a plot of K values deduced from
similar experiments for binding of Lys-13 to LUVs
composed of PC and different fractions of PS. K increases
exponentially with the mol % of PS in the vesicles, i.e., the
binding energy increases linearly with the percent of PS in
the membrane. The results are consistent both with previous
observations of binding of basic/hydrophobic peptides cor-
responding to the basic effector domain of MARCKS or the
juxtamembrane domain of the EGFR (10,33), and with
theory (34), if one assumes that binding of basic and basic/
hydrophobic peptides to PC/PS membrane does not produce
redistribution of PS.
We validated the results of the centrifugation technique
by comparing the binding of Alexa488-labeled Lys-13 using
both centrifugation and an FCS technique described in detail
elsewhere (33); bothmethods produced similar results, as shown
inFig. 2B. (n.b., The afﬁnity ofAlexa488-labeledLys-13 for 3:1
PC/PS vesicles is;10-foldweaker than the afﬁnity of 3HNEM-
labeled Lys-13, because the Alexa488 probe is negatively
charged, whereas the NEM label is electrically neutral.)
Neither basic nor basic/hydrophobic peptides
induce self-quenching of monovalent acidic lipids
We examined whether addition of either unlabeled Lys-13
or MARCKS(151–175) produces self-quenching of NBD-
labeled PS when the ﬂuorescent lipid is present in the
vesicles at a fraction just below the level that produces self-
quenching. We ﬁrst determined the mol fraction of NBD-
labeled PC or PS in the vesicles where the probe begins to
self-quench. Fig. 3 A plots the percentage of self-quenching
versus the fraction of NBD-labeled lipids in the vesicles (the
results of experiments with NBD-PC and NBD-PS were
averaged): .4% NBD-labeled lipid produces signiﬁcant self-
quenching. Previous studies showed that NBD-PS self-
quenches when present at mol fractions .5% (46), because
the average distance between labeled lipids is comparable to
the Fo¨rster radius for NBD (Ro ; 35A˚). Thus, for vesicles
with 4% NBD-labeled PS, even a minor redistribution of
acidic lipids should increase self-quenching.
Fig. 3 B plots the percentage of self-quenching of NBD-PS
calculated from Eq. 2 versus peptide concentration: neither
MARCKS(151–175) nor Lys-13 produce measurable self-
quenching when they bind to vesicles with 4% NBD-PS. The
simplest interpretation is that membrane-bound basic and
basic/hydrophobic peptides do not enhance the local con-
centration of NBD-PS. In contrast, adding high-molecular-
weight polylysine (;2000 residues) does induce signiﬁcant
self-quenching of NBD-PS (e.g., 100 pM produces 20%
quenching; data not shown), suggesting that it may laterally
sequester monovalent lipids. An extended 2000-residue
polylysine molecule could encircle the 100-nm vesicle and
cross over itself; presumably such a bound molecule would
diffuse only slowly on the surface of the vesicle. The dif-
ference in diffusion rates between membrane-bound Lys-13
and polylysine could account for the presumed lateral
sequestration by the latter. We have not examined exper-
imentally whether membrane-bound basic peptides that have
structure (e.g., amphipathic helices) laterally sequester PS.
These self-quenching experiments suggest that small
membrane-bound basic and basic/hydrophobic unstructured
peptides do not sequester monovalent acidic lipids; in con-
trast, Fig. 3 C shows that the same peptides produce sig-
niﬁcant sequestration of the BODIPY-labeled polyvalent
acidic lipid PIP2. (A control experiment shows MARCKS
(151–175) produces similar quenching of NBD-PIP2 and
BODIPY-PIP2; data not shown). Fig. 3 C agrees with
FIGURE 3 Binding of MARCKS(151–175) and Lys-13 does not produce
self-quenching of NBD-PS. (A) Self-quenching of NDB-PS (or NBD-PC)
versus mol fraction of NBD-PS (or NBD-PC) in 5:1 PC/PS 100 nm LUVs.
Each point represents an average (6 SD) of at least three independent vesicle
preparations. (B) Neither MARCKS(151–175) (d) nor Lys-13 (s) produce
signiﬁcant self-quenching of NBD-PS when they bind to 83:13:4 PC/PS/
NBD-PS LUVs. (C) Addition of either MARCKS(151–175) (d) or Lys-13
(s) produces strong self-quenching of BODIPY-TMR-PIP2 in 99:1 PC/
BODIPY-TMR-PIP2 LUVs, because the peptides laterally sequester the
PIP2 (8,9).
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previous self-quenching, FRET, spin-label, and kinetic mea-
surements (8,9). We discuss elsewhere the different factors
that contribute to the quenching observed in Fig. 3 C (9).
Diffusion of membrane-bound basic and basic/
hydrophobic peptides
Membrane-bound Lys-13 diffuses more rapidly than lipids
We measured the lateral diffusion of Alexa-labeled Lys-13
bound to the inner leaﬂet of PC/PS GUVs using FCS. Fig. 4 A
shows an LSM image of a 10-mm-diameter GUV labeled
with DiD to aid visualization. Fig. 4 B is a cartoon showing a
GUV with the confocal volume positioned on the top central
region and Alexa-labeled peptides diffusing on the inner
leaﬂet of the GUV. The FCS instrument’s software produces
autocorrelation curves that correspond to peptides moving in
and out of the confocal volume.
Fig. 4 C (green) shows an example of an autocorrelation
curve for Alexa488-Lys-13 diffusing on a 3:1 PC/PS
membrane. We used the least-squares ﬁt of Eq. 3 to the
autocorrelation curve to calculate the residency time, td
;890 ms, in the confocal volume and the Einstein relation
(Eq. 4) to calculate the diffusion coefﬁcient, D, of the
membrane-bound peptide. Fig. 4 D shows that D ¼ 7 6
1 3 108 cm2/s (6 SD, n ¼ 48) for Lys-13 bound to GUVs
containing 25% PS. All diffusion measurements were made
at room temperature, 21 6 1C.
Fig. 4 D shows the diffusion coefﬁcient of Lys-13 bound
to PC/PS GUVS is approximately twofold greater than the
diffusion coefﬁcient of a lipid (compare left and right bars), a
difference that is statistically signiﬁcant (P , 0.05). Spe-
ciﬁcally, we measured the diffusion coefﬁcient of BODIPY-
FL-PC in PC/PS GUVs, D ¼ 2.9 6 0.4 3 108 cm2/s (n ¼
11), and of BODIPY-TMR-PIP2 incorporated into PC/PS
GUVs, D ¼ 3.3 6 0.8 3 108 cm2/s (n ¼ 33), as shown in
Fig. 4, C (red) and D. (As a control, we measured the
diffusion of BODIPY-TMR-PIP2 incorporated into the outer
leaﬂet of preformed GUVs (by exposing them to PIP2
micelles), D ¼ 3.3 6 0.7 3 108 cm2/s (n ¼ 23).) These
values (;3 3 108 cm2/s) agree qualitatively with the
diffusion coefﬁcients of unsaturated chain lipids reported pre-
viously (47–50). Speciﬁcally,Wagner andTamm (51) showed
that NBD-labeled PE and PIP2 had similar diffusion coefﬁ-
cients in planar supported bilayers.
We conﬁrmed that we were measuring true lateral
diffusion of Alexa488-Lys-13 (rather than desorption of
the peptide and aqueous diffusion) by repeating the diffusion
measurements on PC/PS GUVs containing different mol
fractions of acidic lipid. (The forward rate constant of a basic
peptide with a PC/PS membrane is diffusion-limited (52),
and the equilibrium association constant increases exponen-
tially with the mol fraction of acidic lipid (Fig. 2 B). Thus,
both the rate constant for the peptide moving off the
membrane and the fraction of peptide free in the aqueous
phase inside the vesicle will decrease markedly as the mol
fraction of PS increases.) Table 2 shows that the average
diffusion coefﬁcient of the membrane-bound peptide is
6.53 108 cm2/s with 5:1, 4:1, 3:1, and 2:1 PC/PS vesicles,
i.e., it is independent of the mol fraction of PS in the vesicle.
FIGURE 4 (A) A representative LSM confocal image of
a GUV used for FCS measurements. The vesicle contains
0.01% red ﬂuorescent lipid DiD for LSM imaging. Scale
bar, 5 mm. (B) Cartoon showing a GUV (red circle) with
Alexa488-labeled basic peptide (green circles with blue
bars) bound to its inner leaﬂet. The confocal volume
(green hourglass shape) is positioned at the top of the
GUV. (C) Autocorrelation curves of Alexa488-Lys-13
diffusing on a 4:1 PC/PS GUV (black with green ﬁt) and
BODIPY-TMR-PIP2 diffusing in a 10:1 PC/PS GUV
(black with red ﬁt). The black curves represent the
experimentally determined autocorrelation functions, the
green curve the ﬁt of Eq. 3, with td ¼ 890 ms and D ¼
6.5 3 108 cm2/s for Alexa488-Lys-13, the red curve the
ﬁt of Eq. 3, with td ¼ 2 ms and D ¼ 3 3 108 cm2/s for
BODIPY-TMR-PIP2. (D) Diffusion constants of mem-
brane-bound Alexa488-Lys-13 and BODIPY-TMR-PIP2
in GUVS determined by FCS. Bars indicate average values
6 SD. Note that Lys-13 diffuses twofold more rapidly on
the 3:1 PC/PS vesicles than on the 99:1 PC/PIP2 vesicles,
and that the diffusion constant of the peptide bound to the
PC/PIP2 vesicles is the same as the diffusion constant of a
lipid, as expected theoretically.
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Hence, the measured diffusion coefﬁcient does not depend
on the rate at which the peptide moves off the membrane.
Finally, wemeasured the diffusion of peptides bound to the
outer leaﬂet of the GUVs to ensure that our measurements did
not reﬂect data on peptides trapped betweenmultiple lamellae
of the vesicle: D ¼ 6 3 108 cm2/s for peptides bound to
either the inner or outer leaﬂet of the membrane (Table 2). In
summary, Fig. 4 D shows Alexa488-Lys-13 bound to PC/PS
vesicles diffuses twofold more rapidly than lipids.
Basic peptides bound to PC/PIP2 vesicles diffuse as slowly
as lipids
We measured the lateral diffusion of Alexa488-Lys-13
bound to 99:1 PC/PIP2 GUVs. Fig. 4 D and Table 2 show
D ¼ 3 6 1 3 108 cm2/s (n ¼ 15), a value identical, within
experimental error, with diffusion measurements of BODI-
PY-TMR-PIP2 incorporated into PC/PS GUVs, D ¼ 3.3 6
0.8 3 108 cm2/s (n ¼ 33). Why does Alexa488-Lys-13
diffuse twofold more slowly when bound to 99:1 PC/PIP2
versus 3:1 PC/PS vesicles? Lys-13 has an identical afﬁnity
for 3:1 PC/PS (Fig. 2) and 99:1 PC/PIP2 (8) vesicles, K ¼
106 M1. Previous studies showed that when Lys-13 binds to
PC/PIP2 membranes, three PIP2 molecules diffuse toward
the peptide to form an electrostatic binding site (8); the
peptide cannot diffuse laterally at a speed faster than that of
the lipid without desorbing from the binding site. Thus it is
the nature of the binding, rather than the magnitude of the
afﬁnity for the PC/PIP2 vesicle, that determines the value of
D. Our FCS result thus agrees with the expectation: the
peptide diffuses together with the laterally sequestered PIP2.
Basic/hydrophobic peptides also diffuse more rapidly on
PC/PS than PC/PIP2 membranes
We measured the lateral diffusion of two basic/hydrophobic
peptides,Alexa488-MARCKS(151–175) andAlexa488-ErbB1
(645–660) (Table 1), which corresponds to the juxtamem-
brane region of the EGFR/ErbB receptor (10) bound to PC/PS
GUVs: D ;4 3 108 cm2/s and ;6 3 108 cm2/s, respec-
tively (Table 2), and is independent of the mol fraction of PS
in the vesicle (or binding afﬁnity). These values are slightly
but signiﬁcantly (P , 0.05) higher than the D of lipids.
MeasurementswithAlexa488-MARCKS(151–175) bound to
99:1 PC/PIP2 GUVs (Table 2) show that D ¼ 2.3 6 0.7 3
108 cm2/s (n ¼ 52), slightly but signiﬁcantly (P , 0.05)
slower than the D of the same peptide bound to PC/PS
vesicles.
Incorporating physiological (1%) levels of PIP2 into
PC/PS GUVS slows the diffusion of basic and
basic/hydrophobic peptides
Table 3 shows the diffusion coefﬁcients of the three
Alexa488-labeled peptides bound to PC/PS/PIP2 GUVs.
Comparison of the value in Tables 2 and 3 shows that the
peptide diffusion constants are slightly faster on PC/PS
versus PC/PS/PIP2 membranes. The latter composition is a
better reﬂection of the cytoplasmic leaﬂet of a plasma mem-
brane, which contains both monovalent (e.g., PS) and poly-
valent (e.g., PIP2) acidic lipids. Previous experiments (e.g.,
FRET) showed that basic and basic/hydrophobic peptides
sequester PIP2 even when the membrane contains physio-
logical mol fractions (15–30%) of monovalent acidic lipids
and 100-fold less PIP2 (9).
DISCUSSION
Three different types of experiments strongly suggest that
binding of either basic (e.g., F-A-MARCKS(151–175), Lys-
13, Arg-13) or basic/hydrophobic (e.g., MARCKS(151–
175)) peptides to membranes produces no signiﬁcant lateral
sequestration of monovalent acidic lipids. First, Arg-13 and
F-A-MARCKS(151–175) bind with the same afﬁnity to
DMPC/DMPG vesicles in the gel and liquid-crystalline state
TABLE 2 Diffusion coefﬁcients of basic and basic/hydrophobic peptides bound to GUVs composed of POPC and either
POPS or porcine PIP2 as determined by FCS
Peptide
Diffusion coefﬁcient of membrane-bound peptide (108 cm2/s)
83:17 PC/PS 80:20 PC/PS 75:25 PC/PS 67:33 PC/PS 99:1 PC/PIP2
Alexa488- Lys-13
On inner leaﬂet 7 6 1 6 6 2 7 6 1 6 6 2 3 6 1
n ¼ 17 n ¼ 12 n ¼ 48 n ¼ 13 n ¼ 15
On outer leaﬂet 6.5 6 0.9 6 6 1
n ¼ 16 n ¼ 18
Alexa488-MARCKS(151–175)
On inner leaﬂet 4 6 1 4.4 6 0.6 4 6 1 4.1 6 0.8 2.3 6 0.7
n ¼ 59 n ¼ 15 n ¼ 17 n ¼ 12 n ¼ 52
On outer leaﬂet 4.1 6 0.6 5.2 6 0.9 4.3 6 0.5
n ¼ 4 n ¼ 10 n ¼ 14
Alexa488-ErbB1(645–660)
On inner leaﬂet 5 6 1 7 6 1 5 6 2
n ¼ 14 n ¼ 51 n ¼ 18
Values are presented as mean 6 SD. n, number of experiments.
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(Fig. 1 B). As discussed above, the simplest interpretation is
that the peptide also does not perturb the random distribution
of the lipids when it binds to the ﬂuid membrane. Earlier
measurements of the effect of Lys-5 on the electrophoretic
mobility (z potential) of DMPC/DMPG multilamellar ves-
icles supports our interpretation: the peptide binds to the
same degree at temperatures above and below the transition
temperature (31). Second, the binding afﬁnity of Lys-13
(Fig. 2 B) for PC/PS vesicles increases exponentially with
the mol fraction of monovalent acidic lipids, as was observed
previously with basic/hydrophobic peptides (10,33). This is
the theoretically predicted result if the peptides do not
perturb the initial random distribution of acidic lipids in the
membrane (34). Speciﬁcally, if binding of Lys-13 to the PC/
PS membrane produced lateral sequestration of PS, a simple
theoretical analysis of the entropy price paid for this redis-
tribution suggests that Fig. 2 B would be a curve, steep at
the low mol fractions, less steep at high mol fractions of PS
(J. Nagle, Carnegie Mellon University, personal communi-
cation, 2005). Third, Fig. 3 B shows that neither Lys-13 nor
MARCKS(151–175) produces self-quenching of NBD-PS
when it binds to the membrane, in agreement with a previous
report that membrane-adsorbed Lys-5 does not laterally
sequester spin-labeled monovalent acidic lipids (53).
Our interpretation of these results is that membrane-
adsorbed basic or basic/hydrophobic peptides concentrate or
sequester monovalent acidic lipids minimally, if at all. In
contrast, membrane-bound basic or basic/hydrophobic pep-
tides laterally sequester polyvalent PIP2 strongly (9). The-
oretical analyses indicate that peptide binding should
concentrate monovalent acidic lipids in the electrical double
layer adjacent to the binding site, albeit less strongly than
polyvalent lipids (26,27,29). Why do our experimental re-
sults indicate no signiﬁcant sequestration of PS next to an
adsorbed basic peptide? We suspect that our diffusion mea-
surements provide a clue: a membrane-bound basic peptide
diffuses twofold more rapidly than the lipids in a PC/PS
membrane (Fig. 4 D, Table 2). We admit, however, that we
do not understand the phenomenon fully.
Structural studies show that the ﬁve Phe residues of
MARCKS(151–175) insert into the membrane to the level of
the acyl chains, suggesting that the diffusion coefﬁcient of the
bound peptide might be expected to be the same as that of the
membrane lipids. Our measurements, however, indicate that
this basic/hydrophobic peptide diffuses slightly faster than the
lipids in a PC/PS membrane (14,16,17). One possible, albeit
speculative, explanation is that the Phe residues move in and
out of the membrane rapidly (e.g., approximately every
microsecond). This is not unreasonable, because electro-
static interactions provide most of the binding energy:
MARCKS(151–175) binds to 5:1 PC/PS membranes with K
¼ 106M1, four orders ofmagnitude higher thanK¼ 102M1
for neutral PC membranes (33). Thus the Phe residues could
hop out of the bilayer but if the peptide remains close to the
surface it would retain its electrostatic binding energy, and
could diffuse relatively rapidly parallel to themembrane.Once
the Phe residues repenetrate, the peptide should diffuse at
about the same speed as a lipid. This mechanism could explain
both why the peptide diffuses more rapidly than a lipid, and
why it does not sequester PS. Alternatively, the Phe residues
could simply slide rapidly between the lipid molecules.
Why is the diffusion constant of Lys-13 bound to the
membrane much slower than the diffusion in a bulk aqueous
solution? We know that basic peptides (e.g., Lys-13) adsorb
outside the envelope of the polar headgroup region (they do
not increase the surface pressure of a monolayer when they
bind), but we don’t know if they are located zero, one, or two
water layers away from the surface. If there is no water
between the bound peptide and the lipids, perhaps a ‘‘no-
slip’’ boundary condition results in a relatively slow dif-
fusion. Faxen’s law (54) predicts that the drag exerted by a
surface on a sphere extends for several diameters from the
surface. The molecular roughness of the surface, as revealed
by MD simulations and experiments (55,56), presumably
also plays a role in slowing the diffusion constant of the
membrane-bound peptides.
Why does incorporating PIP2 into the membrane slow
the diffusion of membrane-bound peptides? Previous studies
show that binding of basic and basic/hydrophobic peptides
redistributes or sequesters polyvalent acidic lipids such as
PIP2 in both PC/PIP2 (8) and PC/PS/PIP2 membranes (9).
Atomic models show that the sequestered PIP2 produces an
‘‘electrostatic well’’ at the binding site (8,9). Our results
show that basic and basic/hydrophobic peptides bound to
PC/PIP2 or PC/PS/PIP2 membranes have diffusion coefﬁ-
cients comparable to those of lipids (Table 3). To diffuse
laterally at a rate faster than lipids, the peptide would have
to desorb from the electrostatic well, a process that would
require signiﬁcant energy. In contrast, a peptide adsorbed to
a PC/PS membrane experiences an essentially uniform
electrostatic potential and can thus diffuse laterally without
signiﬁcant electrostatic energy cost.
TABLE 3 Diffusion coefﬁcients of basic and basic/hydrophobic
peptides bound to the inner leaﬂet of PC/PS/PIP2 GUVs,
as determined by FCS
Diffusion coefﬁcient of
membrane-bound peptide (108 cm2/s)
Peptide
82:17:1
PC/PS/PIP2
83:17:0.1
PC/PS/PIP2
73:25:1
PC/PS/PIP2
74:26:0.1
PC/PS/PIP2
Alexa488-Lys-13 4.0 6 0.7 4.0 6 0.9
n ¼ 20 n ¼ 12
Alexa488-MARCKS
(151–175)
3.5 6 0.8 3.1 6 0.6
n ¼ 10 n ¼ 22
Alexa488-ErbB1
(645–660)
3.3 6 0.6 3.2 6 0.7
n ¼ 9 n ¼ 16
Values are presented as mean 6 SD. n, number of experiments.
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PIP2 sequestration and raft formation on the
inner leaﬂet of a plasma membrane
The existence of cholesterol-enriched rafts in cell membranes
remains highly controversial and several recent reviews
concluded that the evidence supporting raft formation is ‘‘not
yet compelling’’ (57–60). Formation of rafts in the cytoplas-
mic leaﬂet is particularly problematical: Silvius (61) showed
that membranes composed of physiological levels of choles-
terol and other lipids found in the cytoplasmic leaﬂet do not
form coexisting lipid domains. Munro (57) concluded that
‘‘there is as yet no clear evidence for a mechanism for the
formation of lipid domains in the inner leaﬂet of the plasma
membrane.’’ Anderson and Jacobson (62), however, have
suggested that proteins may nucleate raft formation by
attracting lipid shells enriched in cholesterol. The work
reported here, together with earlier structural studies (13–17),
suggests a mechanism by which basic/hydrophobic clusters
on proteins may attract shells of lipids enriched in cholesterol.
MARCKS, the EGFR, and gravin all contain basic/hydro-
phobic clusters that may interact with the plasma membrane.
There is indirect evidence that MARCKS (63,64), the
EGFR (65–67), and gravin (68) associate with noncaveolar
cholesterol-enriched lipid rafts. The hydrophobic Phe resi-
dues in the MARCKS basic effector domain insert into the
membrane to the level of the acyl chains, dragging the
adjacent residues into the polar headgroup region (see Fig.
1 of Gambhir et al. (9) or Fig. 3 a of McLaughlin and Murray
(12)). This increases the local lateral surface pressure, which
could attract lipids with a small polar headgroup, such as
cholesterol, and nucleate raft formation. (McIntosh and
Simon (69) and Lee (70) review authoritatively how lipid
properties can effect membrane lateral organization and the
effects of lateral pressure proﬁles in membranes.) This could
occur, however, only if basic/hydrophobic clusters on pro-
teins diffuse sufﬁciently slowly to allow cholesterol seques-
tration. One way to retard lateral diffusion of the protein is
for a basic/hydrophobic cluster to bind PIP2; our results
suggest this could reduce lateral diffusion of the cluster to a
value that would allow sequestration of other lipids. (Cross-
linking or aggregration could also slow lateral diffusion:
caveolin, which also contains a basic/hydrophobic cluster,
forms self-aggregates in caveolae.) In agreement with this
suggestion, noncaveolar cholesterol-enriched rafts in bio-
logical membranes appear to contain an enhanced mol frac-
tion of PIP2 (71). Sid Simon and Tom McIntosh (Duke
University, personal communication, 2006) suggested an-
other mechanism by which basic/hydrophobic clusters might
nucleate the formation of rafts. They point out that when a
basic/hydrophobic cluster penetrates the polar headgroup
region of the cytoplasmic leaflet, the thickness of this leaﬂet
immediately below the cluster will decrease (72) as the lipid
chains curl into the region to avoid forming a vacuum. This
locally slimmed-down region of the cytoplasmic leaﬂet
should attract lipids with longer-than-average chains, e.g.,
sphingomyelin, to the corresponding region of the extracel-
lular leaﬂet; sphingomyelin could then nucleate local raft
formation on the extracellular leaﬂet. This Simon/McIntosh
mechanism could act in parallel with the lateral pressure
mechanism. The hypothesis that basic/hydrophobic clusters
could nucleate raft formation is highly speculative, but could
be tested by experimental approaches such as magic angle
spinning NMR, ﬂuorescence, and diffraction.
Note added in proof: Our observation that small unstructured basic and
basic/hydrophobic peptides diffuse more rapidly than lipids when bound to
PC/PS vesicles cannot be extrapolated to all amphipathic helical peptides.
Frey and Tamm (73) showed that a cytochrome c oxidase subunit IV signal
peptide diffuses ;1.5-fold more rapidly than lipids when bound to POPC
membranes but ;1.5-fold less rapidly than lipids when bound more
strongly to 4:1 POPC/POPG membranes. The degree to which these am-
phipathic, helical, membrane-bound peptides laterally concentrate mono-
valent acidic lipids has apparently not been investigated to date.
We thank John Nagle for a valuable theoretical contribution to the
interpretation of Fig. 2 B; Avinon Ben-Shaul, Nir Ben-Tal, Sylvio May,
Tom McIntosh, Diana Murray, Kim Sharp, and Sid Simon for helpful
discussions; and William Woturski for excellent technical input with
respect to the FCS measurements.
This work was supported by National Institutes of Health grant R-37
GM24971 to S.M. and Deutsche Forschungsgemeinschaft SFB 563-A4 to
J.R.
REFERENCES
1. Sigal, C. T., W. Zhou, C. A. Buser, S. McLaughlin, and M. D. Resh.
1994. Amino-terminal basic residues of Src mediate membrane binding
through electrostatic interaction with acidic phospholipids. Proc. Natl.
Acad. Sci. USA. 91:12253–12257.
2. Buser, C. A., C. T. Sigal, M. D. Resh, and S. McLaughlin. 1994.
Membrane binding of myristylated peptides corresponding to the NH2
terminus of Src. Biochemistry. 33:13093–13101.
3. Hancock, J. F., K. Cadwallader, H. Paterson, and C. J. Marshall. 1991.
A CAAX or a CAAL motif and a second signal are sufﬁcient for
plasma membrane targeting of ras proteins. EMBO J. 10:4033–4039.
4. Ghomashchi, F., X. Zhang, L. Liu, and M. H. Gelb. 1995. Binding of
prenylated and polybasic peptides to membranes: afﬁnities and in-
tervesicle exchange. Biochemistry. 34:11910–11918.
5. Leventis, R., and J. R. Silvius. 1998. Lipid-binding characteristics of
the polybasic carboxy-terminal sequence of K-Ras4B. Biochemistry.
37:7640–7648.
6. McLaughlin, S., and A. Aderem. 1995. The myristoyl-electrostatic
switch: a modulator of reversible protein-membrane interactions.
Trends Biochem. Sci. 20:272–276.
7. Okeley, N. M., and M. H. Gelb. 2004. A designed probe for acidic
phospholipids reveals the unique enriched anionic character of the
cytosolic face of the mammalian plasma membrane. J. Biol. Chem.
279:21833–21840.
8. Wang, J., A. Gambhir, G. Hangyas-Mihalyne, D. Murray, U.
Golebiewska, and S. McLaughlin. 2002. Lateral sequestration of
phosphatidylinositol 4,5-bisphosphate by the basic effector domain of
myristoylated alanine-rich C kinase substrate is due to nonspeciﬁc
electrostatic interactions. J. Biol. Chem. 277:34401–34412.
9. Gambhir, A., G. Hangyas-Mihalyne, I. Zaitseva, D. S. Caﬁso, J. Wang,
D. Murray, S. N. Pentyala, S. O. Smith, and S. McLaughlin. 2004.
Electrostatic sequestration of PIP2 on phospholipid membranes by
basic/aromatic regions of proteins. Biophys. J. 86:2188–2207.
10. McLaughlin, S., S. O. Smith, M. J. Hayman, and D. Murray. 2005. An
electrostatic engine model for autoinhibition and activation of the
Membranes, Basic Peptides, Acidic Lipids 597
Biophysical Journal 91(2) 588–599
epidermal growth factor receptor (EGFR/ErbB) family. J. Gen.
Physiol. 126:41–53.
11. Wang, J., A. Gambhir, S. McLaughlin, and D. Murray. 2004. A
computational model for the electrostatic sequestration of PI(4,5)P2 by
membrane-adsorbed basic peptides. Biophys. J. 86:1969–1986.
12. McLaughlin, S., and D. Murray. 2005. Plasma membrane phosphoin-
ositide organization by protein electrostatics. Nature. 438:605–611.
13. Qin, Z., and D. S. Caﬁso. 1996. Membranes structure of protein kinase
C and calmodulin binding domain of myristoylated alanine rich C
kinase substrate determined by site-directed spin labeling. Biochemis-
try. 35:2917–2925.
14. Victor, K., J. Jacob, and D. S. Caﬁso. 1999. Interactions controlling the
membrane binding of basic protein domains: phenylalanine and the
attachment of the myristoylated alanine-rich C-kinase substrate protein
to interfaces. Biochemistry. 38:12527–12536.
15. Wang, J., A. Arbuzova, G. Hangyas-Mihalyne, and S. McLaughlin.
2001. The effector domain of myristoylated alanine-rich C kinase
substrate binds strongly to phosphatidylinositol 4,5-bisphosphate.
J. Biol. Chem. 276:5012–5019.
16. Ellena, J. F., M. C. Burnitz, and D. S. Caﬁso. 2003. Location of the
myristoylated alanine-richC-kinase substrate (MARCKS) effector domain
in negatively charged phospholipid bicelles. Biophys. J. 85:2442–2448.
17. Zhang, W., E. Crocker, S. McLaughlin, and S. O. Smith. 2003. Binding
of peptides with basic and aromatic residues to bilayer membranes:
phenylalanine in the myristoylated alanine-rich C kinase substrate
effector domain penetrates into the hydrophobic core of the bilayer.
J. Biol. Chem. 278:21459–21466.
18. Cho, W., and R. V. Stahelin. 2005. Membrane-protein interactions in
cell signaling and membrane trafﬁcking. Annu. Rev. Biophys. Biomol.
Struct. 34:119–151.
19. Taniguchi, H., and S. Manenti. 1993. Interaction of myristoylated
alanine-rich protein kinase C substrate (MARCKS) with membrane
phospholipids. J. Biol. Chem. 268:9960–9963.
20. Kim, J., T. Shishido, X. Jiang, A. Aderem, and S. McLaughlin. 1994.
Phosphorylation, high ionic strength, and calmodulin reverse the binding
ofMARCKS to phospholipid vesicles. J. Biol. Chem. 269:28214–28219.
21. Swierczynski, S. L., and P. J. Blackshear. 1995. Membrane association
of the myristoylated alanine-rich C kinase substrate (MARCKS)
protein. J. Biol. Chem. 270:13436–13445.
22. Ohmori, S., N. Sakai, Y. Shirai, H. Yamamoto, E. Miyamoto, N.
Shimizu, and N. Saito. 2000. Importance of protein kinase C targeting
for the phosphorylation of its substrate, myristoylated alanine-rich
C-kinase substrate. J. Biol. Chem. 275:26449–26457.
23. Fivaz, M., and T. Meyer. 2005. Reversible intracellular translocation of
KRas but not HRas in hippocampal neurons regulated by Ca21/
calmodulin. J. Cell Biol. 170:429–441.
24. Sidhu, R. S., R. R. Clough, and R. P. Bhullar. 2003. Ca21/calmodulin
binds and dissociates K-RasB from membrane. Biochem. Biophys. Res.
Commun. 304:655–660.
25. Bivona, T. G., S. E. Quatela, B. O. Bodemann, I. M. Ahearn, M. J.
Soskis, A. Mor, J. Miura, H. H. Wiener, L. Wright, S. G. Saba, D. Yim,
A. Fein, et al. 2006. PKC regulates a farnesyl-electrostatic switch on
K-Ras that promotes its association with Bcl-XL on mitochondria and
induces apoptosis. Mol. Cell. 21:481–493.
26. May, S., D. Harries, and A. Ben-Shaul. 2000. Lipid demixing and
protein-protein interactions in the adsorption of charged proteins on
mixed membranes. Biophys. J. 79:1747–1760.
27. Haleva, E., N. Ben-Tal, and H. Diamant. 2004. Increased concentration
of polyvalent phospholipids in the adsorption domain of a charged
protein. Biophys. J. 86:2165–2178.
28. Mbamala, E. C., A. Ben-Shaul, and S. May. 2005. Domain formation
induced by the adsorption of charged proteins on mixed lipid mem-
branes. Biophys. J. 88:1702–1714.
29. Tzlil, S., and A. Ben-Shaul. 2005. Flexible charged macromolecules on
mixed ﬂuid lipid membranes: theory and Monte Carlo simulations.
Biophys. J. 89:2972–2987.
30. Montich, G., S. Scarlata, S. McLaughlin, R. Lehrmann, and J. Seelig.
1993. Thermodynamic characterization of the association of small
basic peptides with membranes containing acidic lipids. Biochim.
Biophys. Acta. 1146:17–24.
31. Kim, J., M. Mosior, L. A. Chung, H. Wu, and S. McLaughlin. 1991.
Binding of peptides with basic residues to membranes containing
acidic phospholipids. Biophys. J. 60:135–148.
32. Ben-Tal, N., B. Honig, R. M. Peitzsch, G. Denisov, and S.
McLaughlin. 1996. Binding of small basic peptides to membranes
containing acidic lipids: theoretical models and experimental results.
Biophys. J. 71:561–575.
33. Rusu, L., A. Gambhir, S. McLaughlin, and J. Radler. 2004. Fluores-
cence correlation spectroscopy studies of peptide and protein binding
to phospholipid vesicles. Biophys. J. 87:1044–1053.
34. Arbuzova, A., L. Wang, J. Wang, G. Hangyas-Mihalyne, D. Murray,
B. Honig, and S. McLaughlin. 2000. Membrane binding of peptides
containing both basic and aromatic residues. Experimental studies with
peptides corresponding to the scaffolding region of caveolin and the
effector region of MARCKS. Biochemistry. 39:10330–10339.
35. Buser, C. A., and S. McLaughlin. 1998. Ultracentrifugation technique
for measuring the binding of peptides and proteins to sucrose-loaded
phospholipid vesicles. Methods Mol. Biol. 84:267–281.
36. Akashi, K., H. Miyata, H. Itoh, and K. Kinosita, Jr. 1996. Preparation
of giant liposomes in physiological conditions and their characteriza-
tion under an optical microscope. Biophys. J. 71:3242–3250.
37. Moscho, A., O. Orwar, D. T. Chiu, B. P. Modi, and R. N. Zare. 1996.
Rapid preparation of giant unilamellar vesicles. Proc. Natl. Acad. Sci.
USA. 93:11443–11447.
38. Bagatolli, L. A., T. Parasassi, and E. Gratton. 2000. Giant phospholipid
vesicles: comparison among the whole lipid sample characteristics
using different preparation methods: a two photon ﬂuorescence micro-
scopy study. Chem. Phys. Lipids. 105:135–147.
39. Peitzsch, R. M., and S. McLaughlin. 1993. Binding of acylated
peptides and fatty acids to phospholipid vesicles: pertinence to
myristoylated proteins. Biochemistry. 32:10436–10443.
40. Hess, S. T., and W. W. Webb. 2002. Focal volume optics and
experimental artifacts in confocal ﬂuorescence correlation spectros-
copy. Biophys. J. 83:2300–2317.
41. Schwille, P., U. Haupts, S. Maiti, and W. W. Webb. 1999. Molecular
dynamics in living cells observed by ﬂuorescence correlation spectros-
copy with one- and two-photon excitation. Biophys. J. 77:2251–
2265.
42. Zar, J. H. 1998. Biostatistical Analysis. Prentice Hall, Englewood
Cliffs, NJ.
43. Findlay, E. J., and P. G. Barton. 1978. Phase behavior of synthetic
phosphatidylglycerols and binary mixtures with phosphatidylcholines
in the presence and absence of calcium ions. Biochemistry. 17:2400–
2405.
44. Lewis, R. N., Y. P. Zhang, and R. N. McElhaney. 2005. Calorimetric
and spectroscopic studies of the phase behavior and organization of
lipid bilayer model membranes composed of binary mixtures of
dimyristoylphosphatidylcholine and dimyristoylphosphatidylglycerol.
Biochim. Biophys. Acta. 1668:203–214.
45. Derzko, Z., and K. Jacobson. 1980. Comparative lateral diffusion of
ﬂuorescent lipid analogues in phospholipid multibilayers. Biochemis-
try. 19:6050–6057.
46. Hoekstra, D. 1982. Fluorescence method for measuring the kinetics of
Ca21-induced phase separations in phosphatidylserine-containing
lipid vesicles. Biochemistry. 21:1055–1061.
47. Schwille, P., J. Korlach, and W. W. Webb. 1999. Fluorescence
correlation spectroscopy with single-molecule sensitivity on cell and
model membranes. Cytometry. 36:176–182.
48. Korlach, J., P. Schwille, W. W. Webb, and G. W. Feigenson. 1999.
Characterization of lipid bilayer phases by confocal microscopy and
ﬂuorescence correlation spectroscopy. Proc. Natl. Acad. Sci. USA.
96:8461–8466.
598 Golebiewska et al.
Biophysical Journal 91(2) 588–599
49. Kahya, N., D. Scherfeld, K. Bacia, B. Poolman, and P. Schwille. 2003.
Probing lipid mobility of raft-exhibiting model membranes by ﬂuores-
cence correlation spectroscopy. J. Biol. Chem. 278:28109–28115.
50. Zhang, L., and S. Granick. 2005. Slaved diffusion in phospholipid
bilayers. Proc. Natl. Acad. Sci. USA. 102:9118–9121.
51. Wagner, M. L., and L. K. Tamm. 2001. Reconstituted syntaxin1A/
SNAP25 interacts with negatively charged lipids as measured by lateral
diffusion in planar supported bilayers. Biophys. J. 81:266–275.
52. Arbuzova, A., J. Wang, D. Murray, J. Jacob, D. S. Caﬁso, and S.
McLaughlin. 1997. Kinetics of interaction of the myristoylated alanine-
rich C kinase substrate, membranes, and calmodulin. J. Biol. Chem.
272:27167–27177.
53. Kleinschmidt, J. H., and D. Marsh. 1997. Spin-label electron spin
resonance studies on the interactions of lysine peptides with phospho-
lipid membranes. Biophys. J. 73:2546–2555.
54. Svoboda, K., and S. M. Block. 1994. Biological applications of optical
forces. Annu. Rev. Biophys. Biomol. Struct. 23:247–285.
55. Tieleman, D. P., S. J. Marrink, and H. J. C. Berendsen. 1997. A
computer perspective of membranes: molecular dynamics studies of
lipid bilayer systems. Biochim. Biophys. Acta. 1331:235–270.
56. White, S. H., and W. C. Wimley. 1998. Hydrophobic interactions
of peptides with membrane interfaces. Biochim. Biophys. Acta. 1376:
339–352.
57. Munro, S. 2003. Lipid rafts: elusive or illusive? Cell. 115:377–388.
58. Edidin, M. 2003. The state of lipid rafts: from model membranes to
cells. Annu. Rev. Biophys. Biomol. Struct. 32:257–283.
59. McMullen, T. P. W., R. N. A. H. Lewis, and R. N. McElhaney. 2004.
Cholesterol-phospholipid interactions, the liquid-ordered phase and
lipid rafts in model and biological membranes. Curr. Opin. Colloid
Interface Sci. 8:459–468.
60. Nichols, B. 2005. Without a raft. Nature. 436:638–639.
61. Silvius, J. R. 2003. Role of cholesterol in lipid raft formation:
lessons from lipid model systems. Biochim. Biophys. Acta. 1610:
174–183.
62. Anderson, R. G. W., and K. Jacobson. 2002. A role for lipid shells in
targeting proteins to caveolae, rafts, and other lipid domains. Science.
296:1821–1825.
63. Laux, T., K. Fukami, M. Thelen, T. Golub, D. Frey, and P. Caroni.
2000. GAP43, MARCKS, and CAP23 modulate PI(4,5)P2 at
plasmalemmal rafts, and regulate cell cortex actin dynamics through
a common mechanism. J. Cell Biol. 149:1455–1472.
64. Caroni, P. 2001. Actin cytoskeleton regulation through modulation of
PI(4,5)P2 rafts. EMBO J. 20:4332–4336.
65. Carpenter, G. 2000. The EGF receptor: a nexus for trafﬁcking and
signaling. Bioessays. 22:697–707.
66. Pike, L. J. 2005. Growth factor receptors, lipid rafts and caveolae: An
evolving story. Biochim. Biophys. Acta. 1746:260–273.
67. Orr, G., D. Hu, S. Ozcelik, L. K. Opresko, H. S. Wiley, and S. D.
Colson. 2005. Cholesterol dictates the freedom of EGF receptors and
HER2 in the plane of the membrane. Biophys. J. 89:1362–1373.
68. Streb, J. W., and J. M. Miano. 2005. Cross-species sequence analysis
reveals multiple charged residue-rich domains that regulate nuclear/
cytoplasmic partitioning and membrane localization of a kinase anchor-
ing protein 12 (SSeCKS/gravin). J. Biol. Chem. 280:28007–28014.
69. McIntosh, T. J., and S. A. Simon. 2006. Roles of bilayer material
properties in function and distribution of membrane proteins. Annu.
Rev. Biophys. Biomol. Struct. 35:177–198.
70. Lee, A. G. 2004. How lipids affect the activities of integral membrane
proteins. Biochim. Biophys. Acta. 1666:62–87.
71. Pike, L. J. 2004. Lipid rafts: heterogeneity on the high seas. Biochem.
J. 378:281–292.
72. Ebihara, L., J. E. Hall, R. C. MacDonald, T. J. McIntosh, and S. A.
Simon. 1979. Effect of benzyl alcohol on lipid bilayers. A comparisons
of bilayer systems. Biophys. J. 28:185–196.
73. Frey, S., and L. K. Tamm. 1990. Membrane insertion and lateral
diffusion of ﬂuorescence-labelled cytochrome c oxidase subunit IV
signal peptide in charged and uncharged phospholipid bilayers. Bio-
chem. J. 272:713–719.
Membranes, Basic Peptides, Acidic Lipids 599
Biophysical Journal 91(2) 588–599
